Drug Profile
Inactivated rabies vaccine - Liaoning ChengDa Biotechnology
Alternative Names: Chromatographically purified rabies vaccine - Liaoning ChengDa Biotechnology; Perfusion cell culture based rabies vaccine - Liaoning ChengDa Biotechnology; Purified Vero cell rabies vaccine - Liaoning ChengDa Biotechnology; PVRV - Liaoning ChengDa Biotechnology; SPEEDA; TRCS CPRV - Liaoning ChengDa Biotechnology; TRCS SPEEDA; Vero cell derived rabies vaccine - Liaoning ChengDa BiotechnologyLatest Information Update: 02 Jan 2023
Price :
$50
*
At a glance
- Originator Liaoning ChengDa Biotechnology
- Developer Biovalys; Liaoning ChengDa Biotechnology; Thai Red Cross Society
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rabies
Most Recent Events
- 02 Jan 2023 Phase II development in Rabies (Prevention, In children, In infants) still ongoing in Thailand (IM) (TCTR20200202001)
- 15 Nov 2020 Phase-II clinical trials in Rabies (Prevention, In children, In infants) in Thailand (IM) (TCTR20200202001)
- 04 Nov 2020 Liaoning Cheng Da Biotechnology plans a clinical trial for Rabies (In infants, In children, Prevention) in Thailand (IM) (TCTR20200202001)